drs. M.B. Busstra

Medicine and Dentistry

1. Androgen 9%
2. Association 19%
3. Biochemical Recurrence 12%
4. Biopsy 30%
5. Cancer Recurrence 9%
6. Combination Therapy 10%
7. Computed Tomography 9%
8. Computer Assisted Tomography 11%
9. Continence 7%
10. Diagnosis 15%
11. Evaluation Study 20%
12. Examination 19%
13. Gallium 68 13%
14. Gastrin Releasing Peptide Receptor 9%
15. Gleason Score 17%
16. Inpatient 14%
17. Intraductal Carcinoma 13%
18. Lesion 7%
19. Ligand 9%
20. Logistic Regression Analysis 8%
21. Magnetic Resonance Imaging 21%
22. Malignant Neoplasm 7%
23. Man 31%
24. Meta-Analysis 9%
25. Neoplasm 24%
26. Nerve-Sparing Surgery 22%
27. Odds Ratio 12%
28. Patient 59%
29. Peptide Receptor 9%
30. Perineural Invasion 9%
31. PET-CT 8%
32. Positron Emission Tomography 29%
33. Positron Emission Tomography-Computed Tomography 10%
34. Predictor 14%
35. Prostate Cancer 100%
36. Prostate Specific Antigen 12%
37. Prostate Specific Membrane Antigen 29%
38. Prostatectomy 55%
39. Radiation Therapy 19%
40. Receptor Antagonist 12%
41. Receptor Expression 6%
42. Screening 9%
43. Sexual Function 9%
44. Surgical Margin 15%
45. Systematic Review 9%
46. Therapeutic Procedure 6%
47. Treatment Response 5%
48. Urine Incontinence 11%
49. Urology 19%